On the other hand, RhoB has demonstrated tumor suppressor characteristics by inhibiting cell invasion and metastasis, and enhancing therapy response, leading to better clinical outcomes such as bladder, ovarian and head-neck cancers [31–34]. This evidence concerns the gene RHOB and neoplasm.